Archimed, HCAP, Hg and Kain Capital are circling radiology assets as demand for imaging climbs. Rising cancer incidence and complex disease prevalence push hospitals and clinics to expand MRI, CT and X‑ray capacity, creating steady cash flow for owners. The firms see both service revenues and equipment sales as attractive, recurring sources.

Investors target a fragmented sector where consolidation can lift margins. Buyers aim to lock in contracts for high‑margin radiotracers and imaging hardware, leveraging scale to negotiate better terms with manufacturers. The push follows a broader health‑care wave where private capital backs niche specialties that benefit from predictable reimbursement.

Deal activity signals confidence that imaging will remain a growth engine despite economic headwinds. As providers scramble for capacity, PE groups plan to bundle service sites with technology vendors, extracting synergies and positioning for eventual exits. The market’s upward trajectory gives firms a clear path to generate returns.